Migraine

For 30 days, migraineurs were randomized to an FDA-approved dental device to help jaw clenching or a placebo device.

Researchers assessed whether physical activity was associated with less analgesic use for headache disorders.

According to authors of a cross-sectional study, abnormalities in thalamic functional connectivity are a likely mechanism for migraine development.

Researchers found closure of patent foramen ovale could result in reduced monthly migraine days.

New research indicates that migraine frequency may be inversely linked with a diet high in anti-inflammatory properties.

Data showed erenumab helped improve migraine functional impact when compared with placebo.

Migraineurs and those with tension-type headaches reported poorer physical and cognitive work ability compared with their headache-free counterparts.

Individuals in Taiwan who suffer from migraine were at an increased risk of developing neovascular age-related macular degeneration.

Findings of the largest genome-wide association study conducted among migraineurs to date revealed novel risk factors for the condition, stratified by aura presence.

Researchers assess the role of cognitive behavioral therapy in treating pediatric migraine.

New survey findings reveal a significant association between migraine and irritable bowel syndrome.

An analysis of data collected in 2018 shows that more work is needed to address unmet needs in episodic migraine.

Researchers in Turkey analyzed the impacts of mask and disinfectant use among patients with confirmed migraine diagnoses.

Results of a study conducted among Finnish migraineurs highlight a link between the condition and hypertension.

Researchers identified a link between migraine characteristics and diets rich in certain nutrients.

New research identified risk factors for postoperative migraine and compared the incidence of migraine following general or neuraxial anesthesia.

A combination of onabotulinumtoxinA and a calcitonin gene-related peptide monoclonal antibody appears effective and safe in patients with chronic migraine, according to real-world data.

Findings of a post hoc analysis revealed a beneficial safety and efficacy profile for erenumab use among migraineurs with aura.

This year's most-read migraine articles covered a range of topics, such as new causes of migraine, its link to bipolar disorder, and COVID-19's impact on existing migraine.

Those with episodic migraine receiving erenumab can evaluate the treatment's efficacy after 3 months, according to a post hoc analysis.

Researchers examined the safety and efficacy of erenumab in patients with episodic migraine for whom up to 4 previous treatments have been ineffective.

An article published in Medical Sciences assesses the potential association between sodium chloride (salt) withdrawal and migraine.

A cross-sectional study using data from United Kingdom Biobank found that migraine is gender-dependently associated with physically demanding jobs and shift work.

In a small study, researchers identified high nasal-paranasal sinus nitric oxide and carbon monoxide levels as potential migraine biomarkers.

Researchers sought to classify opioid and triptan use for migraine based on geographic location.

Researchers in Iran sought to quantify headaches related to personal protective equipment (PPE) among frontline health care workers.

Study findings show those with celiac disease tend to experience migraine more frequently than healthy individuals.

New study results indicate that initiation of a diet intended to lower blood pressure could benefit migraineurs.

Migraineurs often report auditory symptoms during and in-between attacks.

Results of a phase 4 study show erenumab to be superior in efficacy and tolerability outcomes among migraineurs compared with topiramate.